DR. HAVEN GARBER M.D.
Prescription History 1982923090
Internal Medicine in Boston, MA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. HAVEN GARBER M.D., an active Internal Medicine specialist practicing in Boston, MA. Our medical registry currently tracks 6 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 202 documented patient claims. Among these therapy options, the most frequently utilized medication is Anastrozole, which accounts for 76 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other MA PrescribersVs. MA Avg |
|---|---|---|---|
| Anastrozole | 76 | $20.65▼ below MA avg | ≈ Typical |
About Anastrozole: Anastrozole is used to treat breast cancer in women after menopause. Show more ▾ Some breast cancers are made to grow faster by a natural hormone called estrogen. Anastrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women. In 2024, this provider wrote 76 Medicare prescriptions for Anastrozole, about 1.2 times the volume of the typical Massachusetts prescriber of this medication (64.9). Medicare paid an average of $20.65 per fill, versus $24.20 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 174.7 30-Day Fills standardized to 30-day supplies 5,240 Days of Medication total across all patients in 2024 | |||
| Letrozole | 43 | $27.86 | ≈ Typical |
About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. In 2024, this provider wrote 43 Medicare prescriptions for Letrozole, about 78% of the volume of the typical Massachusetts prescriber of this medication (55.4). Medicare paid an average of $27.86 per fill, versus $25.90 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 121 30-Day Fills standardized to 30-day supplies 3,630 Days of Medication total across all patients in 2024 | |||
| IbrancePalbociclib | 25 | $21,668.82 | ≈ Typical |
About Ibrance: Palbociclib is used to treat a certain type of breast cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. Has antineoplastic activity; specific inhibitor of cyclin-dependent kinases 4 & 6. In 2024, this provider wrote 25 Medicare prescriptions for Ibrance, about the same volume as the typical Massachusetts prescriber of this medication (24.2). Medicare paid an average of $21,668.82 per fill, versus $15,383.42 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34 30-Day Fills standardized to 30-day supplies 980 Days of Medication total across all patients in 2024 | |||
| VerzenioAbemaciclib | 25 | $14,870.71 | ≈ Typical |
About Verzenio: This medication is used to treat certain types of breast cancer. Show more ▾ Abemaciclib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. A cell cycle inhibitor. In 2024, this provider wrote 25 Medicare prescriptions for Verzenio, about the same volume as the typical Massachusetts prescriber of this medication (22.9). Medicare paid an average of $14,870.71 per fill, versus $14,757.87 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25 30-Day Fills standardized to 30-day supplies 700 Days of Medication total across all patients in 2024 | |||
| Prochlorperazine Maleate | 21 | $7.69▼ below MA avg | ≈ Typical |
About Prochlorperazine Maleate: This medication is used to treat severe nausea and vomiting from certain causes (for example, after surgery or cancer treatment). Show more ▾ Prochlorperazine belongs to a class of drugs known as phenothiazines. This medication is not recommended for use in children younger than 2 years or in children going through surgery. A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612) In 2024, this provider wrote 21 Medicare prescriptions for Prochlorperazine Maleate, about 78% of the volume of the typical Massachusetts prescriber of this medication (27). Medicare paid an average of $7.69 per fill, versus $13.98 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 21 30-Day Fills standardized to 30-day supplies 159 Days of Medication total across all patients in 2024 | |||
| Ondansetron Hcl | 12 | $6.71▼ below MA avg | ▼ Less than typical |
About Ondansetron Hcl: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. It works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2024, this provider wrote 12 Medicare prescriptions for Ondansetron Hcl, about half the volume of the typical Massachusetts prescriber of this medication (26.9). Medicare paid an average of $6.71 per fill, versus $13.94 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 12 30-Day Fills standardized to 30-day supplies 87 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. HAVEN GARBER M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Internal Medicine prescribing approach at this Boston, MA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
